Indian Journal of Urology Users online:6585  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml

Kumar Niraj, Yadav Siddharth, Kumar Sandeep, Saurav Kumar, Prasad Vishnu, Vasudeva Pawan

Year : 2019| Volume: 35| Issue : 3 | Page no: 202-207

   This article has been cited by
1 Delayed 68Ga-PSMA PET/CT Image-Guided Biopsy for Low-Grade Adenocarcinoma in Benign Prostatic Hyperplasia
Sampath Santhosh, Godwin Jeeva
Clinical Nuclear Medicine. 2021; 46(4): e190
[Pubmed]  [Google Scholar] [DOI]
2 Predictive value of standard serum markers for bone metastases in prostate cancer
Semra Ozdemir, Ahmet Resit Ersay, Fulya Koc Ozturk, Beril Su Ozdemir
African Journal of Urology. 2021; 27(1)
[Pubmed]  [Google Scholar] [DOI]
3 Diagnostic Accuracy of 68Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis
Swayamjeet Satapathy, Harmandeep Singh, Rajender Kumar, Bhagwant Rai Mittal
American Journal of Roentgenology. 2021; 216(3): 599
[Pubmed]  [Google Scholar] [DOI]
4 Is there any additional value to 68Ga-PSMA PET/CT in patients with suspicion of prostate cancer despite negative MRI and systematic biopsy?
Joris G. Heetman, Jules Lavalaye, Sandrine van Selm, Erik J. van der Hoeven, Harm H. van Melick, Roderick C. van den Bergh
Minerva Urologica e Nefrologica. 2020; 72(4)
[Pubmed]  [Google Scholar] [DOI]
5 New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers
Karin Ried, Tasnuva Tamanna, Sonja Matthews, Peter Eng, Avni Sali
Frontiers in Oncology. 2020; 10
[Pubmed]  [Google Scholar] [DOI]


Read this article